Share the post "Procter & Gamble Hygiene And Health Care ‘s Q3 2024-25 Latest News: Profit Up by 17.34% Year-on-Year"
Highlights
🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 10.08 % in the past year, substantial increase in net sales/revenue by 9.91 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -37.68 %, Marginal increase in other income during this quarter, up by 14.24%. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Procter & Gamble Hygiene and Health Care Limited. Notable increase of 17.34 % in net profit Year to Year, Procter & Gamble Hygiene and Health Care Limited’s profitability increased by 26.75 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 17.35 % Year to Year. EPS increased by 26.75 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 1133.43 Cr | Rs. 1135.16 Cr | Rs. 1247.63 Cr | + 9.91 % | + 10.08 % |
Expenses | Rs. 823.69 Cr | Rs. 844.68 Cr | Rs. 876.7 Cr | + 3.79 % | + 6.44 % |
Operating Profit | Rs. 309.74 Cr | Rs. 290.48 Cr | Rs. 370.93 Cr | + 27.7 % | + 19.76 % |
OPM % | 27.33 % | 25.59 % | 29.73 % | + 4.14 % | + 2.4 % |
Other Income | Rs. 15.58 Cr | Rs. 8.5 Cr | Rs. 9.71 Cr | + 14.24 % | -37.68 % |
Interest | Rs. 2.55 Cr | Rs. 1.91 Cr | Rs. 6.62 Cr | + 246.6 % | + 159.61 % |
Depreciation | Rs. 14.26 Cr | Rs. 11.7 Cr | Rs. 9.89 Cr | -15.47 % | -30.65 % |
Profit before tax | Rs. 308.51 Cr | Rs. 285.37 Cr | Rs. 364.13 Cr | + 27.6 % | + 18.03 % |
Tax % | 25.8 % | 25.75 % | 26.24 % | + 0.49 % | + 0.44 % |
Net Profit | Rs. 228.9 Cr | Rs. 211.9 Cr | Rs. 268.59 Cr | + 26.75 % | + 17.34 % |
EPS in Rs | Rs. 70.51 | Rs. 65.28 | Rs. 82.74 | + 26.75 % | + 17.35 % |
Today, we’re looking at Procter & Gamble Hygiene and Health Care Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 10.08 %. However, it did see a marginal increase of 9.91 % from the previous quarter. Expenses ticked up slightly by 3.79 % quarter-on-quarter, aligning with the annual rise of 6.44 %. Operating profit, while up 19.76 % compared to last year, faced a quarter-on-quarter increase of 27.7 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.4 %, but an expansion of 4.14 % sequentially. Other income rose by 14.24 % compared to the last quarter, despite an annual decline of -37.68 %. Interest expenses surged remarkably by 246.6 % from the previous quarter, yet the year-over-year increase remains at a moderate 159.61 %. Depreciation costs fell by -15.47 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -30.65 %. Profit before tax grew annually by 18.03 % but saw an increase from the preceding quarter by 27.6 %.
Tax expenses as a percentage of profits increased slightly by 0.44 % compared to last year, with a more notable quarter-on-quarter increase of 0.49 %. Net profit rose by 17.34 % year-on-year but experienced a 26.75 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 17.35 % but a quarterly rise of 26.75 %. In summary, Procter & Gamble Hygiene and Health Care Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 1133.43 Cr | Rs. 1135.16 Cr | Rs. 1247.63 Cr | + 9.91 % | + 10.08 % |
Expenses | Rs. 823.69 Cr | Rs. 844.68 Cr | Rs. 876.7 Cr | + 3.79 % | + 6.44 % |
Operating Profit | Rs. 309.74 Cr | Rs. 290.48 Cr | Rs. 370.93 Cr | + 27.7 % | + 19.76 % |
Net Profit | Rs. 228.9 Cr | Rs. 211.9 Cr | Rs. 268.59 Cr | + 26.75 % | + 17.34 % |
EPS in Rs | Rs. 70.51 | Rs. 65.28 | Rs. 82.74 | + 26.75 % | + 17.35 % |
In reviewing Procter & Gamble Hygiene and Health Care Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 10.08 % year-on-year growth, however, there was a minor increase of 9.91 % from the previous quarter. Expenses rose by 6.44 % compared to the previous year, with a 3.79 % increase quarter-on-quarter. Operating Profit surged by 19.76 % annually, and saw a 27.7 % increase from the last quarter.
Net Profit showed yearly increase of 17.34 %, and experienced a 26.75 % increase from the previous quarter. Earnings Per Share (EPS) rose by 17.35 % annually, however rose by 26.75 % compared to the last quarter. In essence, while Procter & Gamble Hygiene and Health Care Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.